Keys for Treating Pediatric Patients With Skin of Color
When treating pediatric patients, knowing how to appropriately use topical steroids in this patient population is essential, according to Dr. Karan Lal, a dermatologist in Scottsdale, Ariz. Next Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Lal, who shares how to taper topical steroids and the role of non-steroidal agents. Hear the latest in the safety profile of topica …
When treating pediatric patients, knowing how to appropriately use topical steroids in this patient population is essential, according to Dr. Karan Lal, a dermatologist in Scottsdale, Ariz. Next Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Lal, who shares how to taper topical steroids and the role of non-steroidal agents. Hear the latest in the safety profile of topica … Continue reading "Keys for Treating Pediatric Patients With Skin of Color"
Lebrikizumab is a humanized immunoglobulin G4 (IgG4) monoclonal antibody that selectively targets IL-13, a key cytokine implicated in the pathogenesis of type 2 inflammatory diseases.1 Lebrikizumab binds IL-13 with high affinity and a slow dissociation rate, which prevents heterodimerization of the IL-13 receptor alpha-1 subunit (IL-13Rα1) with the IL-4 receptor alpha (IL-4Rα) signaling complex. … 
Topical calcineurin inhibitors may offer several benefits over topical steroids in treating the scaly, lichenified periorbital plaques in this patient with atopic dermatitis, including:
A. More cost effective
B. Quicker onset of action
C. Decreased irritant potential
D. Absence of reports of cutaneous atrophy
E. Once daily application
To find out the correct answer and read the … 
Everyday Health recently addressed the "invisible burden of atopic dermatitis" – the impact of the condition on a patient’s mental health. As a psychophysiological disorder, psychological stress can worsen atopic dermatitis (AD) flares, which in turn creates more inflammation in the body that stresses the nervous system. Chronic itch and sleep disturbances compound the distress, contributing … 
Dermatologists must become comfortable prescribing JAK inhibitors in patients with skin of color in order to provide high-quality dermatologic care. That’s according to Dr. Brett King, a dermatologist in Fairfield, Conn., who was the first dermatologist to show that JAK inhibitors as a medicine class were effective in treating a spectrum of dermatologic conditions, including alopecia areata and …